|
Volumn 15, Issue 3, 2005, Pages 157-165
|
Drug-prescribing challenges during pregnancy
|
Author keywords
Complications; Pregnancy; Prescription drugs
|
Indexed keywords
ALKYLATING AGENT;
AMINOGLYCOSIDE;
AMPICILLIN;
ANDROGEN;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANTIDIABETIC AGENT;
ANTIHYPERTENSIVE AGENT;
ANTIMETABOLITE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBAMAZEPINE;
CARBIMAZOLE;
CITALOPRAM;
CLINDAMYCIN;
COUMARIN DERIVATIVE;
DECONGESTIVE AGENT;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FLUCONAZOLE;
FLUOXETINE;
GLIBENCLAMIDE;
IMMUNOSUPPRESSIVE AGENT;
INSULIN;
LITHIUM;
METFORMIN;
MISOPROSTOL;
NON PRESCRIPTION DRUG;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PAROXETINE;
PENICILLAMINE;
PHENYTOIN;
PROCAINAMIDE;
PSEUDOEPHEDRINE;
RETINOID;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
STEROID;
SULFONYLUREA DERIVATIVE;
THALIDOMIDE;
VALPROIC ACID;
XENOBIOTIC AGENT;
ARTICLE;
DEPRESSION;
DEVELOPMENTAL DISORDER;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG MARKETING;
FINANCIAL MANAGEMENT;
GASTROSCHISIS;
GOVERNMENT;
HUMAN;
INFORMATION;
INTRAUTERINE GROWTH RETARDATION;
LACTATION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NURSING;
PREGNANCY;
PRESCRIPTION;
REPRODUCTION;
TERATOGENICITY;
|
EID: 19444378676
PISSN: 09575847
EISSN: None
Source Type: Journal
DOI: 10.1016/j.curobgyn.2005.03.005 Document Type: Article |
Times cited : (12)
|
References (12)
|